7 June

Clin J Am Soc Nephrol https://cjasn.asnjournals.org/

• 19:00
  COVID-19 Vaccination for Patients Undergoing Long-Term Hemodialysis - Korst, U. K. H. Clin J Am Soc Nephrol
• 19:00
  Medicare Bundled Payment Policy and Anemia Care: Perspectives from a Patient with Kidney Disease - Thomas, C. Clin J Am Soc Nephrol
• 19:00
  Conflicts of Interest and the Trustworthiness of Clinical Practice Guidelines - Mathew, A., Clase, C. M. Clin J Am Soc Nephrol
• 19:00
  Safety of SGLT2 Inhibitors in CKD: Walking the Fine Line - Dobre, M. Clin J Am Soc Nephrol
• 19:00
  Fractional Excretion of Sodium (FENa): An Imperfect Tool for a Flawed Question - Seethapathy, H., Fenves, A. Z. Clin J Am Soc Nephrol
• 19:00
  Clinical Utility of COVID-19 Vaccination in Patients Undergoing Hemodialysis - Oliver, M. J., Blake, P. G. Clin J Am Soc Nephrol
• 19:00
  International Variation in Time on Peritoneal Dialysis: Time for a Closer Look? - Rivara, M. B. Clin J Am Soc Nephrol
• 19:00
  Diagnostic Performance of Fractional Excretion of Sodium for the Differential Diagnosis of Acute Kidney Injury: A Systematic Review and Meta-Analysis - Abdelhafez, M., Nayfeh, T., Atieh, A., AbuShamma, O., Babaa, B., Baniowda, M., Hrizat, A., Hasan, B., Hassett, L., Hamadah, A., Gharaibeh, K. Clin J Am Soc Nephrol
  Background and objectives AKI is classified as prerenal, intrinsic, and postrenal. Prerenal AKI and intrinsic AKI represent the most common causes for AKI in hospitalized patients. This study aimed to examine the accuracy of the fractional excretion of sodium for distinguishing intrinsic from (...)
• 19:00
  Apolipoprotein L1 High-Risk Genotypes and Albuminuria in Sub-Saharan African Populations - Brandenburg, J.-T., Govender, M. A., Winkler, C. A., Boua, P. R., Agongo, G., Fabian, J., Ramsay, M. Clin J Am Soc Nephrol
  Background and objectives Recessive inheritance of African-specific APOL1 kidney risk variants is associated with higher risk of nondiabetic kidney disease, progression to kidney failure, and early-onset albuminuria that precedes eGFR decline. The effect of APOL1 risk variants on kidney (...)
• 19:00
  PCSK9 and Cardiovascular Disease in Individuals with Moderately Decreased Kidney Function - Kheirkhah, A., Lamina, C., Kollerits, B., Schachtl-Riess, J. F., Schultheiss, U. T., Forer, L., Sekula, P., Kotsis, F., Eckardt, K.-U., Kronenberg, F., for the GCKD Investigators, GCKD Investigators, Eckardt, Meiselbach, Schneider, Schiffer, Prokosch, Ba?rthlein, Beck, Reis, Ekici, Becker, Becker-Grosspitsch, Alberth-Schmidt, Hausknecht, Weigel, Walz, Ko?ttgen, Schultheiss, Kotsis, Meder, Mitsch, Reinhard, Floege, Saritas, Schaeffner, Baid-Agrawal, Theisen, Haller, Menne, Zeier, Sommerer, Theilinger, Wolf, Busch, Paul, Sitter, Wanner, Krane, Bo?rner-Klein, Bauer, Kronenberg, (...) Clin J Am Soc Nephrol
  Background and objectives Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key regulator of lipid homeostasis. Studies investigating the association between PCSK9 and cardiovascular disease in large cohorts of patients with CKD are limited. Design, setting, participants, & (...)
• 19:00
  Evaluation of Conflicts of Interest among Participants of the Japanese Nephrology Clinical Practice Guideline - Murayama, A., Yamada, K., Yoshida, M., Kaneda, Y., Saito, H., Sawano, T., Shrestha, S., Shrestha, R., Tanimoto, T., Ozaki, A. Clin J Am Soc Nephrol
  Background and objectives Rigorous and transparent management strategies for conflicts of interest and clinical practice guidelines with the best available evidence are necessary for the development of nephrology guidelines. However, there was no study assessing financial and nonfinancial (...)
• 19:00
  Total Kidney Volume Measurements in ADPKD by 3D and Ellipsoid Ultrasound in Comparison with Magnetic Resonance Imaging - Akbari, P., Nasri, F., Deng, S. X., Khowaja, S., Lee, S. H., Warnica, W., Lu, H., Rattansingh, A., Atri, M., Khalili, K., York, P. Clin J Am Soc Nephrol
  Background and objectives Total kidney volume is a validated prognostic biomarker for autosomal dominant polycystic kidney disease. Total kidney volume by magnetic resonance imaging (MRI) and manual segmentation is considered the "reference standard," but it is time consuming and not readily (...)
• 19:00
  Fracture Risk of Sodium-Glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease - Cowan, A., Jeyakumar, N., Kang, Y., Dixon, S. N., Garg, A. X., Naylor, K., Weir, M. A., Clemens, K. K. Clin J Am Soc Nephrol
  Background and objectives Sodium-glucose cotransporter-2 (SGLT2) inhibitors have been associated with a higher risk of skeletal fractures in some randomized, placebo-controlled trials. Secondary hyperparathyroidism and increased bone turnover (also common in CKD) may contribute to the observed (...)
• 19:00
  Severity of COVID-19 after Vaccination among Hemodialysis Patients: An Observational Cohort Study - Ashby, D. R., Caplin, B., Corbett, R. W., Asgari, E., Kumar, N., Sarnowski, A., Hull, R., Makanjuola, D., Cole, N., Chen, J., Nyberg, S., McCafferty, K., Zaman, F., Cairns, H., Sharpe, C., Bramham, K., Motallebzadeh, R., Anwari, K. J., Salama, A. D., Banerjee, D., on behalf of the Pan-London COVID-19 Renal Audit Group, Pan-London COVID-19 Renal Audit Group, Ashby, Caplin, Corbett, Asgari, Kumar, Sarnowski, Hull, Makanjuola, Cole, Chen, Nyberg, McCafferty, Zaman, Cairns, Sharpe, Bramham, Motallebzadeh, Anwari, Salama, Banerjee, Ali, Antonelou, Bennet-Richards, Blunden, Booth, Charif, (...) Clin J Am Soc Nephrol
  Background and objectives Patients receiving hemodialysis are at high risk from coronavirus disease 2019 (COVID-19) and demonstrate impaired immune responses to vaccines. There have been several descriptions of their immunologic responses to severe acute respiratory syndrome coronavirus 2 (...)
• 19:00
  Medicare Bundled Payment Policy on Anemia Care, Major Adverse Cardiovascular Events, and Mortality among Adults Undergoing Hemodialysis - Park, H., Desai, R., Liu, X., Smith, S. M., Hincapie-Castillo, J., Henry, L., Goodin, A., Gopal, S., Pepine, C. J., Mohandas, R. Clin J Am Soc Nephrol
  Background and objectives In 2011, the Centers for Medicare & Medicaid Services implemented bundling of all services for patients receiving dialysis, including erythropoietin-stimulating agents use, and the Food and Drug Administration recommended conservative erythropoietin-stimulating (...)
• 19:00
  Variation in Peritoneal Dialysis Time on Therapy by Country: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study - Lambie, M., Zhao, J., McCullough, K., Davies, S. J., Kawanishi, H., Johnson, D. W., Sloand, J. A., Sanabria, M., Kanjanabuch, T., Kim, Y.-L., Shen, J. I., Pisoni, R. L., Robinson, B. M., Perl, J., the PDOPPS Steering Committee, PDOPPS Steering Committee, Johnson, Perl, Kawanishi, Kim, Kanjanabuch, Davies, Bernardo, Pisoni, Robinson, Shen, Badve, Boudville, Brown, Chow, Collins, Morton, Wilson, Vychytil, Van Biesen, Figueiredo, de Moraes, Brunier, Jain, Jassal, Nessim, Oliver, Price, Quinn, Fang, Szeto, Wang, Fukasawa, Ito, Ryuzaki, Tomo, Manzano, Marshall, Ljungman, Boongird, Boonyakrai, (...) Clin J Am Soc Nephrol
  Background and objectives Quantifying contemporary peritoneal dialysis time on therapy is important for patients and providers. We describe time on peritoneal dialysis in the context of outcomes of hemodialysis transfer, death, and kidney transplantation on the basis of the multinational, (...)
• 19:00
  Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum - Quiroga, B., Soler, M. J., Ortiz, A., Orero, E., Tejedor, S., Mantecon, C. J. J., Gomez Perez, V. O., Marin Franco, A. J., Alfaro Sanchez, C., Puerta Carretero, M., Jaldo Rodriguez, M. T., Carnerero Di Riso, M. A., Martinez, S., Gonzalez, C. C., Cervienka, M., Macias Carmona, N., Arroyo, D., Perez del Valle, K. M., de Arriba, G., Mazuecos, A., Cazorla, J. M., Pereira, M., Gonzalez Parra, E., Sanchez Marquez, M. G., Lancho Novillo, C., Toyos Ruiz, C., Aguilar Cervera, M. C., Munoz Ramos, P., Sanchez Horrillo, A., Jimeno Martin, I., Toapanta, N., Cigarran Guldris, S., Folgueiras Lopez, M., (...) Clin J Am Soc Nephrol
• 19:00
  Correction: Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults with ADPKD: A Randomized Controlled Trial Clin J Am Soc Nephrol
• 19:00
  Statement of Clarification: Chronic Kidney Disease from Polyvinylpyrrolidone Deposition in Persons with Intravenous Drug Use Clin J Am Soc Nephrol
• 19:00
  Sepsis Management for the Nephrologist - Patel, S., Puri, N., Dellinger, R. P. Clin J Am Soc Nephrol
  The definition of sepsis has evolved significantly over the past three decades. Today, sepsis is defined as a dysregulated host immune response to microbial invasion leading to end organ dysfunction. Septic shock is characterized by hypotension requiring vasopressors after adequate fluid (...)
• 19:00
  Mechanical Circulatory Support: Primer for Consultant Specialists - Tam, C. W., Shen, L., Zeidman, A. D., Srivastava, A., Ivascu, N. S. Clin J Am Soc Nephrol
  Mechanical life support therapies exist in many forms to temporarily replace the function of vital organs. Generally speaking, these tools are supportive therapy to allow for organ recovery but, at times, require transition to long-term mechanical support. This review will examine nonrenal (...)
• 19:00
  Hypertension with Kidney Failure - Rivara, M. B., Bansal, N. Clin J Am Soc Nephrol
• 19:00
  The Role of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in the Prevention and Treatment of Diabetic Kidney Disease: Insights from the AMPLITUDE-O Trial - Tommerdahl, K. L., Kendrick, J., Bjornstad, P. Clin J Am Soc Nephrol
• 19:00
  Endothelin Receptor Antagonists for Kidney Protection: Lessons from the SONAR Trial - Heerspink, H. J. L., de Zeeuw, D. Clin J Am Soc Nephrol
• 19:00
  Cannabinoids for Symptom Management in Patients with Kidney Failure: A Narrative Review - Worth, H., OHara, D. V., Agarwal, N., Collister, D., Brennan, F., Smyth, B. Clin J Am Soc Nephrol
  People with kidney failure can experience a range of symptoms that lead to suffering and poor quality of life. Available therapies are limited, and evidence for new treatment options is sparse, often resulting in incomplete relief of symptoms. There is growing interest in the potential for (...)
• 19:00
  Electrolyte and Acid-Base Disorders Associated with Cancer Immunotherapy - Uppal, N. N., Workeneh, B. T., Rondon-Berrios, H., Jhaveri, K. D. Clin J Am Soc Nephrol
  Novel immunotherapy drugs have changed the landscape of cancer medicine. Immune checkpoint inhibitors and chimeric antigen receptor T cells are being used and investigated in almost all types of cancers. Immune-related adverse events have been associated with immunotherapies. AKI has been the (...)

6 May

Clin J Am Soc Nephrol https://cjasn.asnjournals.org/

• 19:00
  Treatment Options for Venous Thromboembolism in Patients Receiving Dialysis - Mavrakanas, T. A. Clin J Am Soc Nephrol
• 19:00
  Functional Assessment of High-Risk APOL1 Genetic Variants - Robinson-Cohen, C. Clin J Am Soc Nephrol
• 19:00
  Learnings from Throwing Paint at the Wall for COVID-19 with an SGLT2 Inhibitor - Tuttle, K. R. Clin J Am Soc Nephrol
• 19:00
  CRRT Fluid Choices: A Solution for a Common Problem? - Vijayan, A. Clin J Am Soc Nephrol
• 19:00
  Association of Phosphate-Containing versus Phosphate-Free Solutions on Ventilator Days in Patients Requiring Continuous Kidney Replacement Therapy - Thompson Bastin, M. L., Stromberg, A. J., Nerusu, S. N., Liu, L. J., Mayer, K. P., Liu, K. D., Bagshaw, S. M., Wald, R., Morris, P. E., Neyra, J. A. Clin J Am Soc Nephrol
  Background and objectives Hypophosphatemia is commonly observed in patients receiving continuous KRT. Patients who develop hypophosphatemia may be at risk of respiratory and neuromuscular dysfunction and therefore subject to prolongation of ventilator support. We evaluated the association of (...)
• 19:00
  Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection: An Analysis of the DARE-19 Randomized Controlled Trial - Heerspink, H. J. L., Furtado, R. H. M., Berwanger, O., Koch, G. G., Martinez, F., Mukhtar, O., Verma, S., Gasparyan, S. B., Tang, F., Windsor, S. L., de Souza-Dantas, V. C., del Sueldo, M., Frankel, R., Javaheri, A., Maldonado, R. A., Morse, C., Mota-Gomes, M., Shemin, D., Silva, O. L., Tognon, A. P., Twahirwa, M., Buenconsejo, J., Esterline, R., Oscarsson, J., Ambery, P., Langkilde, A. M., Kosiborod, M. N. Clin J Am Soc Nephrol
  Background and objectives Patients who were hospitalized with coronavirus disease 2019 (COVID-19) infection are at high risk of AKI and KRT, especially in the presence of CKD. The Dapagliflozin in Respiratory Failure in Patients with COVID-19 (DARE-19) trial showed that in patients (...)
• 19:00
  Provider Perspectives and Clinical Outcomes with Inpatient Telenephrology - Androga, L. A., Zoghby, Z., Ramar, P., Amundson, R. H., dUscio, M., Philpot, L. M., Thorsteinsdottir, B., Kattah, A. G., Albright, R. C. Clin J Am Soc Nephrol
  Background and objectives Despite the dramatic increase in the provision of virtual nephrology care, only anecdotal reports of outcomes without comparators to usual care exist in the literature. This study aimed to provide objective determination of clinical noninferiority of hybrid (...)
• 19:00
  SGLT2 Inhibition and Uric Acid Excretion in Patients with Type 2 Diabetes and Normal Kidney Function - Suijk, D. L. S., van Baar, M. J. B., van Bommel, E. J. M., Iqbal, Z., Krebber, M. M., Vallon, V., Touw, D., Hoorn, E. J., Nieuwdorp, M., Kramer, M. M. H., Joles, J. A., Bjornstad, P., van Raalte, D. H. Clin J Am Soc Nephrol
  Background and objectives Sodium-glucose transporter 2 (SGLT2) inhibitor–induced uric acid lowering may contribute to kidney-protective effects of the drug class in people with type 2 diabetes. This study investigates mechanisms of plasma uric acid lowering by SGLT2 inhibitors in people with (...)
• 19:00
  GWAS of Hematuria - Gagliano Taliun, S. A., Sulem, P., Sveinbjornsson, G., Gudbjartsson, D. F., Stefansson, K., Paterson, A. D., Barua, M. Clin J Am Soc Nephrol
  Background and objectives Glomerular hematuria has varied causes but can have a genetic basis, including Alport syndrome and IgA nephropathy. Design, setting, participants, & measurements We used summary statistics to identify genetic variants associated with hematuria in White British UK (...)
• 19:00
  APOL1 Kidney Risk Variants and Proteomics - Chen, T. K., Surapaneni, A. L., Arking, D. E., Ballantyne, C. M., Boerwinkle, E., Chen, J., Coresh, J., Ko?ttgen, A., Susztak, K., Tin, A., Yu, B., Grams, M. E. Clin J Am Soc Nephrol
  Background and objectives The APOL1 risk variants (G1 and G2) are associated with kidney disease among Black adults, but the clinical presentation is heterogeneous. In mouse models and cell systems, increased gene expression of G1 and G2 confers cytotoxicity. How APOL1 risk variants relate to (...)
• 19:00
  Apixaban versus Warfarin for Treatment of Venous Thromboembolism in Patients Receiving Long-Term Dialysis - Wetmore, J. B., Herzog, C. A., Yan, H., Reyes, J. L., Weinhandl, E. D., Roetker, N. S. Clin J Am Soc Nephrol
  Background and objectives The association of apixaban compared with warfarin for the treatment of venous thromboembolism in patients receiving maintenance dialysis is not well studied. Design, setting, participants, & measurements We conducted a retrospective cohort study of Medicare (...)
• 19:00
  Implementation of a Staff-Assisted Peritoneal Dialysis Program in the United States: A Feasibility Study - Hussein, W. F., Bennett, P. N., Anwaar, A., Atwal, J., Legg, V., Abra, G., Zheng, S., Pravoverov, L., Schiller, B. Clin J Am Soc Nephrol
• 19:00
  The Intensivist's Perspective of Shock, Volume Management, and Hemodynamic Monitoring - Kashani, K., Omer, T., Shaw, A. D. Clin J Am Soc Nephrol
  One of the primary reasons for intensive care admission is shock. Identifying the underlying cause of shock (hypovolemic, distributive, cardiogenic, and obstructive) may lead to entirely different clinical pathways for management. Among patients with hypovolemic and distributive shock, fluid (...)
• 19:00
  Overview of Diagnostic Criteria and Epidemiology of Acute Kidney Injury and Acute Kidney Disease in the Critically Ill Patient - Birkelo, B. C., Pannu, N., Siew, E. D. Clin J Am Soc Nephrol
  Since the description ischuria renalis by William Heberden (1), AKI has remained a prominent complication of critical illness. Beyond KRT, treatment has been limited by the capacity to phenotype this condition. Here, we chronicle the evolution of attempts to classify AKI, including the adoption (...)
• 19:00
  The Transition of a Pediatric Kidney Transplant Recipient from Childhood to Adult Care - Bell, L. E. Clin J Am Soc Nephrol
• 19:00
  Recurrent Podocytopathy after Kidney Transplantation - Garg, N., Djamali, A. Clin J Am Soc Nephrol
• 19:00
  Changing the Trajectory of Heart Failure and Kidney Disease: A Call for Action - Rangaswami, J., Bhalla, V., Chertow, G. M., Harrington, R. A., Staruschenko, A., Tuttle, K., Braunwald, E. Clin J Am Soc Nephrol
• 19:00
  SARS-CoV-2 Vaccine Mandates for Patients on the Kidney Transplant Waitlist: Are They Ethical? - Tallaa, F., Gunaratnam, L., Suri, R. S. Clin J Am Soc Nephrol
• 19:00
  Mass Transport in High-Flux Hemodialysis: Application of Engineering Principles to Clinical Prescription - Mohajerani, F., Clark, W. R., Ronco, C., Narsimhan, V. Clin J Am Soc Nephrol
  An understanding of the processes underlying mass transfer is paramount for the attainment of adequate solute removal in the dialytic treatment of patients with kidney failure. In this review, engineering principles are applied to characterize the physical mechanisms behind the two major modes (...)
• 19:00
  Detecting and Treating Lung Congestion with Kidney Failure - Zoccali, C., Mallamaci, F., Picano, E. Clin J Am Soc Nephrol
  Fluid overload is a common complication in patients with CKD, particularly patients with kidney failure, a population with a very high risk for pulmonary edema. Lung ultrasound is now a well-validated technique that allows for reliable estimates of lung water in clinical practice. Several (...)

7 April

Clin J Am Soc Nephrol https://cjasn.asnjournals.org/

• 19:00
  Knowledge Measurement Can Point to Opportunities, but Has Limits - Franks, K. A. Clin J Am Soc Nephrol
• 19:00
  Symptoms with or because of Kidney Failure? - Abdel-Kader, K. Clin J Am Soc Nephrol
• 19:00
  Could Phosphate Provide a Second Chance for Statin Therapy in Kidney Failure? - Gutierrez, O. M. Clin J Am Soc Nephrol
• 19:00
  Measuring Disease and Transplant Knowledge among Patients with Advanced CKD: Tools to Increase Access and Advance Equity - Urbanski, M. A., Patzer, R. E. Clin J Am Soc Nephrol
• 19:00
  Is There an Ideal Recipe to Increase Home Dialysis Use?: Is It Enough? - Shen, J. I., Perl, J. Clin J Am Soc Nephrol
• 19:00
  Patient-Reported Symptoms and Subsequent Risk of Myocardial Infarction in Chronic Kidney Disease - Lidgard, B., Zelnick, L. R., OBrien, K. D., Bansal, N. Clin J Am Soc Nephrol
  Background and objectives Although patient-reported symptoms often precede acute presentations of cardiovascular disease, patients with nondialysis-requiring CKD are less likely to have typical symptoms of atherosclerotic disease when presenting with acute myocardial infarction. However, the (...)
• 19:00
  Trajectories of Uremic Symptom Severity and Kidney Function in Patients with Chronic Kidney Disease - Wulczyn, K. E., Zhao, S. H., Rhee, E. P., Kalim, S., Shafi, T. Clin J Am Soc Nephrol
  Background and objectives Uremic symptoms, including fatigue, anorexia, pruritus, nausea, paresthesia, and pain, are attributed to the accumulation of organic waste products normally cleared by the kidneys, but whether kidney function is the primary driver of changes in symptom severity over (...)
• 19:00
  Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD: A Randomized Crossover Trial - Kramers, B. J., Koorevaar, I. W., van Gastel, M. D. A., van Goor, H., Hallows, K. R., Heerspink, H. L., Li, H., Leonhard, W. N., Peters, D. J. M., Qiu, J., Touw, D. J., Gansevoort, R. T., Meijer, E. Clin J Am Soc Nephrol
  Background and objectives The vasopressin V2 receptor antagonist tolvaptan is the only drug that has been proven to be nephroprotective in autosomal dominant polycystic kidney disease (ADPKD). Tolvaptan also causes polyuria, limiting tolerability. We hypothesized that cotreatment with (...)
• 19:00
  Chronic Kidney Disease from Polyvinylpyrrolidone Deposition in Persons with Intravenous Drug Use - Stalund, I. V., Gronseth, H., Reinholt, F. P., Svarstad, E., Marti, H.-P., Leh, S. Clin J Am Soc Nephrol
  Background and objectives Persons with intravenous drug use have a higher risk of developing CKD compared with the general population. In Norway, deposits of polyvinylpyrrolidone have been observed in kidney biopsies taken from persons with opioid addiction and intravenous drug use since 2009. (...)
• 19:00
  Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS - Yong, Z.-h., Yu, X.-j., Liu, J.-x., Zhou, F.-d., Wang, S.-x., Zhao, M.-h. Clin J Am Soc Nephrol
  Background and objectives Patients with monoclonal gammopathy and concomitant kidney diseases are frequently found in clinical practice. Some of them are diagnosed with monoclonal gammopathy of renal significance (MGRS) due to the presence of monoclonal Ig–related kidney injuries. This study (...)
• 19:00
  Multifaceted Intervention to Increase the Use of Home Dialysis: A Cluster Randomized Controlled Trial - Manns, B. J., Garg, A. X., Sood, M. M., Ferguson, T., Kim, S. J., Naimark, D., Nesrallah, G. E., Soroka, S. D., Beaulieu, M., Dixon, S. N., Alam, A., Allu, S., Tangri, N. Clin J Am Soc Nephrol
  Background and objectives Home dialysis therapies (peritoneal and home hemodialysis) are less expensive and provide similar outcomes to in-center hemodialysis, but they are underutilized in most health systems. Given this, we designed a multifaceted intervention to increase the use of home (...)
• 19:00
  Association of Serum Phosphate with Efficacy of Statin Therapy in Hemodialysis Patients - Massy, Z. A., Merkling, T., Wagner, S., Girerd, N., Essig, M., Wanner, C., Fellstrom, B. C., Rossignol, P., Zannad, F. Clin J Am Soc Nephrol
  Background and objectives Statins are less efficacious in reducing cardiovascular disease risk in patients on dialysis than in the general population. Recent experimental data showed that phosphate excess promotes cellular de novo cholesterol synthesis through 3-hydroxy-3-methylglutaryl CoA (...)
• 19:00
  The Knowledge Assessment of Renal Transplantation (KART) 2.0: Development and Validation of CKD and Transplant Knowledge Scales - Waterman, A. D., Nair, D., Purnajo, I., Cavanaugh, K. L., Mittman, B. S., Peipert, J. D. Clin J Am Soc Nephrol
  Background and objectives Many individuals with kidney disease, particularly those belonging to racial and ethnic minority groups and whose primary language is not English, lack knowledge related to kidney disease symptoms, physiologic functions of the kidney, and benefits and risks of kidney (...)
• 19:00
  Variations in Deceased Donor Terminal Creatinine Values Reported in the OPTN Data Registry - Yu, K., King, K., Husain, S. A., Mohan, S. Clin J Am Soc Nephrol
• 19:00
  Correction: Prevention of Bloodstream Infections in Patients Undergoing Hemodialysis Clin J Am Soc Nephrol
• 19:00
  Introduction to Critical Care Nephrology and Acute Kidney Injury - Liu, K. D., Palevsky, P. M. Clin J Am Soc Nephrol
• 19:00
  Management of Respiratory Failure: Ventilator Management 101 and Noninvasive Ventilation - Pearson, S. D., Koyner, J. L., Patel, B. K. Clin J Am Soc Nephrol
  Mechanical ventilation is a lifesaving therapy for critically ill patients with respiratory failure, but like all treatments, it has the potential to cause harm if not administered appropriately. This review aims to give an overview of the basic principles of invasive and noninvasive mechanical (...)
• 19:00
  Syndromes of Pseudo-Hyperaldosteronism - Rizzolo, K., Beck, N. M., Ambruso, S. L. Clin J Am Soc Nephrol
• 19:00
  Pattern Recognition versus Pathogenesis: Electrolytes in a Patient with Adrenal Insufficiency - Hoenig, M. P., Lecker, S. H. Clin J Am Soc Nephrol
• 19:00
  In Defense of Normal Saline: Our Perspective - Mikhael, B., Steele, D. J. R., Fenves, A. Z. Clin J Am Soc Nephrol
• 19:00
  Breaking the Barriers to Innovation in Kidney Care: The Time is Now - Nissenson, A. R., Chertow, G. M., Conway, P. T. Clin J Am Soc Nephrol
• 19:00
  Molecular Signatures of Diabetic Kidney Disease Hiding in a Patient with Hypertension-Related Kidney Disease: A Clinical Pathologic Molecular Correlation - Patel, J., Torrealba, J. R., Poggio, E. D., Bebiak, J., Alpers, C. E., Grewenow, S. M., Toto, R. D., Eadon, M. T., for the Kidney Precision Medicine Project Clin J Am Soc Nephrol
  The Kidney Precision Medicine Project (KPMP) seeks to establish a molecular atlas of the kidney in health and disease and improve our understanding of the molecular drivers of CKD and AKI. Herein, we describe the case of a 66-year-old woman with CKD who underwent a protocol KPMP kidney biopsy. (...)
• 19:00
  Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup - Ghannoum, M., Roberts, D. M., Goldfarb, D. S., Heldrup, J., Anseeuw, K., Galvao, T. F., Nolin, T. D., Hoffman, R. S., Lavergne, V., Meyers, P., Gosselin, S., Botnaru, T., Mardini, K., Wood, D. M., for the EXTRIP workgroup Clin J Am Soc Nephrol
  Methotrexate is used in the treatment of many malignancies, rheumatological diseases, and inflammatory bowel disease. Toxicity from use is associated with severe morbidity and mortality. Rescue treatments include intravenous hydration, folinic acid, and, in some centers, glucarpidase. We (...)

7 March

Clin J Am Soc Nephrol https://cjasn.asnjournals.org/

• 19:00
  COVID-19 and Palliative Care: Observations, Extrapolations, and Cautions - Hickey, E. V., Conway, P. T. Clin J Am Soc Nephrol
• 19:00
  Growing Understanding of the Clinical and Serologic Effects of COVID-19 Vaccines in Patients Undergoing Long-Term Dialysis - Hundemer, G. L., Sood, M. M. Clin J Am Soc Nephrol
• 19:00
  Exploring the Role of Inflammation toward the Pathogenesis of Calcium Nephrolithiasis - Sakhaee, K. Clin J Am Soc Nephrol
• 19:00
  Will New Treatment Options for Lupus Nephritis Be Affordable? - Teng, Y. K. O., Rabelink, T. J. Clin J Am Soc Nephrol
• 19:00
  Utilization of Palliative Care for Patients with COVID-19 and Acute Kidney Injury during a COVID-19 Surge - Scherer, J. S., Qian, Y., Rau, M. E., Soomro, Q. H., Sullivan, R., Linton, J., Zhong, J., Chodosh, J., Charytan, D. M. Clin J Am Soc Nephrol
  Background and objectives AKI is a common complication of coronavirus disease 2019 (COVID-19) and is associated with high mortality. Palliative care, a specialty that supports patients with serious illness, is valuable for these patients but is historically underutilized in AKI. The objectives (...)
• 19:00
  Comparison of Aptamer-Based and Antibody-Based Assays for Protein Quantification in Chronic Kidney Disease - Lopez-Silva, C., Surapaneni, A., Coresh, J., Reiser, J., Parikh, C. R., Obeid, W., Grams, M. E., Chen, T. K. Clin J Am Soc Nephrol
  Background and objectives Novel aptamer-based technologies can identify >7000 analytes per sample, offering a high-throughput alternative to traditional immunoassays in biomarker discovery. However, the specificity for distinct proteins has not been thoroughly studied in the context of CKD. (...)
• 19:00
  Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE Trial - Charytan, D. M., Yu, J., Jardine, M. J., Cannon, C. P., Agarwal, R., Bakris, G., Greene, T., Levin, A., Pollock, C., Powe, N. R., Arnott, C., Mahaffey, K. W., on behalf of the CREDENCE study investigators Clin J Am Soc Nephrol
  Background and objectives The effect of including race in the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation on screening, recruitment, and outcomes of clinical trials is unclear. Design, setting, participants, & measurements The inclusion and outcomes of (...)
• 19:00
  Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease - Bae, K. T., Tao, C., Feldman, R., Yu, A. S. L., Torres, V. E., Perrone, R. D., Chapman, A. B., Brosnahan, G., Steinman, T. I., Braun, W. E., Mrug, M., Bennett, W. M., Harris, P. C., Srivastava, A., Landsittel, D. P., Abebe, K. Z., the CRISP and HALT PKD Consortium Clin J Am Soc Nephrol
  Background and objectives The progression of polycystic liver disease is not well understood. The purpose of the study is to evaluate the associations of polycystic liver progression with other disease progression variables and classify liver progression on the basis of patient's age, (...)
• 19:00
  The Cost-Effectiveness of Belimumab and Voclosporin for Patients with Lupus Nephritis in the United States - Mandrik, O., Fotheringham, J., Ren, S., Tice, J. A., Chapman, R. H., Stevenson, M. D., Pearson, S. D., Herron-Smith, S., Agboola, F., Thokala, P. Clin J Am Soc Nephrol
  Background and objectives Despite existing therapies, people with lupus nephritis progress to kidney failure and have reduced life expectancy. Belimumab and voclosporin are two new disease-modifying therapies recently approved for the treatment of lupus nephritis. Design, setting, (...)
• 19:00
  Vaccination and COVID-19 Dynamics in Dialysis Patients - El Karoui, K., Hourmant, M., Ayav, C., Glowacki, F., Couchoud, C., Lapidus, N., on behalf of the REIN Registry Clin J Am Soc Nephrol
  Background and objectives Dialysis patients have a high mortality risk after coronavirus disease 2019 (COVID-19) and an altered immunologic response to vaccines, but vaccine clinical effectiveness remains unknown in this population. Design, setting, participants, & measurements Using (...)
• 19:00
  Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months - Hsu, C. M., Weiner, D. E., Manley, H. J., Aweh, G. N., Ladik, V., Frament, J., Miskulin, D., Argyropoulos, C., Abreo, K., Chin, A., Gladish, R., Salman, L., Johnson, D., Lacson, E. K. Clin J Am Soc Nephrol
  Background and objectives Although most patients receiving maintenance dialysis exhibit initial seroresponse to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, concerns exist regarding the durability of this antibody response. This study evaluated seroresponse over (...)
• 19:00
  Inflammatory Cells in Nephrectomy Tissue from Patients without and with a History of Urinary Stone Disease - Dejban, P., Wilson, E. M., Jayachandran, M., Herrera Hernandez, L. P., Haskic, Z., Wellik, L. E., Sinha, S., Rule, A. D., Denic, A., Koo, K., Potretzke, A. M., Lieske, J. C. Clin J Am Soc Nephrol
  Background and objectives Urinary stone disease has been associated with inflammation, but the specific cell interactions that mediate events remain poorly defined. This study compared calcification and inflammatory cell patterns in kidney tissue from radical nephrectomy specimens of patients (...)
• 19:00
  Renin-Angiotensin-Aldosterone System Inhibitors and the Risk of AKI in COVID-19 Compared with Influenza - Birkelo, B. C., Parr, S. K., Perkins, A. M., Greevy, R. A., Arroyo, J. P., Hung, A. M., Vincz, A. J., Shah, S. C., Kapoor, T., Matheny, M. E., Siew, E. D. Clin J Am Soc Nephrol
• 19:00
  Effect of the Refitted Race-Free eGFR Formula on the CKD Prevalence and Mortality in the Danish Population - Vestergaard, S. V., Heide-Jorgensen, U., Birn, H., Christiansen, C. F. Clin J Am Soc Nephrol
• 19:00
  Catheter-Associated Bloodstream Infections among Patients on Hemodialysis: Progress before and during the COVID-19 Pandemic - Johansen, K. L., Gilbertson, D. T., Wetmore, J. B., Peng, Y., Liu, J., Weinhandl, E. D. Clin J Am Soc Nephrol
  Measures implemented to prevent transmission of severe acute respiratory syndrome coronavirus 2 in outpatient dialysis facilities may also help to prevent catheter-associated bloodstream infections in patients receiving hemodialysis. We used United States Renal Data System data to examine rates (...)
• 19:00
  De Novo Malignancies after Kidney Transplantation - Al-Adra, D., Al-Qaoud, T., Fowler, K., Wong, G. Clin J Am Soc Nephrol
  Cancer is an important outcome after kidney transplantation because it is the second leading cause of death in most Western countries. The excess risk of cancer after transplantation is approximately two to three times higher than the age- and sex-matched general population, driven largely by (...)
• 19:00
  Managing Patients with Failing Kidney Allograft: Many Questions Remain - Davis, S., Mohan, S. Clin J Am Soc Nephrol
  Patients who receive a kidney transplant commonly experience failure of their allograft. Transplant failure often comes with complex management decisions, such as when and how to wean immunosuppression and start the transition to a second transplant or to dialysis. These decisions are made in (...)
• 19:00
  How I Treat Complement-Mediated TMA - Sperati, C. J. Clin J Am Soc Nephrol
• 19:00
  Hyperkalemia with Mineralocorticoid Receptor Antagonist Use in People with CKD: Understanding and Mitigating the Risks - Epstein, M., Pecoits-Filho, R., Clase, C. M., Sood, M. M., Kovesdy, C. P. Clin J Am Soc Nephrol
• 19:00
  Functional Reserve of the Kidney - Armenta, A., Madero, M., Rodriguez-Iturbe, B. Clin J Am Soc Nephrol
  An exploration of the normal limits of physiologic responses and how these responses are lost when the kidney is injured rarely occurs in clinical practice. However, the differences between "resting" and "stressed" responses identify an adaptive reactiveness that is diminished before baseline (...)
• 19:00
  Can Novel Potassium Binders Liberate People with Chronic Kidney Disease from the Low-Potassium Diet?: A Cautionary Tale - St-Jules, D. E., Clegg, D. J., Palmer, B. F., Carrero, J.-J. Clin J Am Soc Nephrol
  The advent of new potassium binders provides an important breakthrough in the chronic management of hyperkalemia for people with CKD. In addition to the direct benefits of managing hyperkalemia, many researchers and clinicians view these new medications as a possible means to safely transition (...)

7 February

Clin J Am Soc Nephrol https://cjasn.asnjournals.org/

• 19:00
  Advancing Patient-Centered Research: Enabling the Patient Voice to Be Heard - Fowler, K. J. Clin J Am Soc Nephrol
• 19:00
  Induction Therapy in Immunologically Well-Matched Recipients: Less May Be More - Potluri, V. S., Bloom, R. D. Clin J Am Soc Nephrol
• 19:00
  What Patients Teach Us About Patient Engagement in Research - Dember, L. M. Clin J Am Soc Nephrol
• 19:00
  Improved Survival after Acute Kidney Injury: Past and Future - Kashani, K., Rule, A. D. Clin J Am Soc Nephrol
• 19:00
  A Heartwarming Role of the Proximal Tubules - Granda, M. L., Kestenbaum, B. Clin J Am Soc Nephrol
• 19:00
  In-Hospital and 1-Year Mortality Trends in a National Cohort of US Veterans with Acute Kidney Injury - Sohaney, R., Yin, H., Shahinian, V., Saran, R., Burrows, N. R., Pavkov, M. E., Banerjee, T., Hsu, C.-y., Powe, N., Steffick, D., Zivin, K., Heung, M., on behalf of the Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team, Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team, Saran, Shahinian, Heung, Gillespie, Morgenstern, Herman, Zivin, Gipson, Modi, Bragg-Gresham, Steffick, Han, Zhang, Wyncott, Powe, Banerjee, Tuot, Hsu, Coresh, McCulloch, Crews, Burrows, Eberhardt, Koyama, Mondesire, Pavkov, Rolka, (...) Clin J Am Soc Nephrol
  Background and objectives AKI, a frequent complication among hospitalized patients, confers excess short- and long-term mortality. We sought to determine trends in in-hospital and 1-year mortality associated with AKI as defined by Kidney Disease Improving Global Outcomes consensus criteria. (...)
• 19:00
  Controlled Study of Decision-Making Algorithms for Kidney Replacement Therapy Initiation in Acute Kidney Injury - Kelly, Y. P., Mistry, K., Ahmed, S., Shaykevich, S., Desai, S., Lipsitz, S. R., Leaf, D. E., Mandel, E. I., Robinson, E., McMahon, G., Czarnecki, P. G., Charytan, D. M., Waikar, S. S., Mendu, M. L. Clin J Am Soc Nephrol
  Background and objectives AKI requiring KRT is associated with high mortality and utilization. We evaluated the use of an AKI Standardized Clinical Assessment and Management Plan (SCAMP) on patient outcomes, including mortality, hospital length of stay, and intensive care unit length of stay. (...)
• 19:00
  Health-Related Quality-of-Life Trajectories over Time in Older Men and Women with Advanced Chronic Kidney Disease - Chesnaye, N. C., Meuleman, Y., de Rooij, E. N. M., Hoogeveen, E. K., Dekker, F. W., Evans, M., Pagels, A. A., Caskey, F. J., Torino, C., Porto, G., Szymczak, M., Drechsler, C., Wanner, C., Jager, K. J., the EQUAL Study Investigators Clin J Am Soc Nephrol
  Background and objectives The effect of sex on longitudinal health-related quality of life remains unknown in CKD. Here we assess differences in the sex-specific evolution of health-related quality of life in older men and women with advanced CKD. Design, setting, participants, & (...)
• 19:00
  Patient and Caregiver Experiences and Attitudes about Their Involvement in Research in Chronic Kidney Disease - Gutman, T., Kelly, A., Scholes-Robertson, N., Craig, J. C., Jesudason, S., Tong, A. Clin J Am Soc Nephrol
  Background and objectives Although patient and caregiver involvement in research is widely advocated to improve the relevance and uptake of study findings, barriers and uncertainties in achieving this goal remain. This study aimed to describe patient and caregiver experiences and perspectives (...)
• 19:00
  Assessment of Proximal Tubular Function by Tubular Maximum Phosphate Reabsorption Capacity in Heart Failure - Emmens, J. E., de Borst, M. H., Boorsma, E. M., Damman, K., Navis, G., van Veldhuisen, D. J., Dickstein, K., Anker, S. D., Lang, C. C., Filippatos, G., Metra, M., Samani, N. J., Ponikowski, P., Ng, L. L., Voors, A. A., ter Maaten, J. M. Clin J Am Soc Nephrol
  Background and objectives The estimated glomerular filtration rate (eGFR) is a crucial parameter in heart failure. Much less is known about the importance of tubular function. We addressed the effect of tubular maximum phosphate reabsorption capacity (TmP/GFR), a parameter of proximal tubular (...)
• 19:00
  Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults with ADPKD: A Randomized Controlled Trial - Nowak, K. L., Farmer-Bailey, H., Wang, W., You, Z., Steele, C., Cadnapaphornchai, M. A., Klawitter, J., Patel, N., George, D., Jovanovich, A., Soranno, D. E., Gitomer, B., Chonchol, M. Clin J Am Soc Nephrol
  Background and objectives Clinical manifestations of autosomal dominant polycystic kidney disease (ADPKD), including evidence of vascular dysfunction, can begin in childhood. Curcumin is a polyphenol found in turmeric that reduces vascular dysfunction in rodent models and humans without ADPKD. (...)
• 19:00
  Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease - Waijer, S. W., Sen, T., Arnott, C., Neal, B., Kosterink, J. G. W., Mahaffey, K. W., Parikh, C. R., de Zeeuw, D., Perkovic, V., Neuen, B. L., Coca, S. G., Hansen, M. K., Gansevoort, R. T., Heerspink, H. J. L. Clin J Am Soc Nephrol
  Background and objectives Clinical trials in nephrology are enriched for patients with micro- or macroalbuminuria to enroll patients at risk of kidney failure. However, patients with normoalbuminuria can also progress to kidney failure. TNF receptor-1, TNF receptor-2, and kidney injury (...)
• 19:00
  Automatic Evaluation of Histological Prognostic Factors Using Two Consecutive Convolutional Neural Networks on Kidney Samples - Marechal, E., Jaugey, A., Tarris, G., Paindavoine, M., Seibel, J., Martin, L., Funes de la Vega, M., Crepin, T., Ducloux, D., Zanetta, G., Felix, S., Bonnot, P. H., Bardet, F., Cormier, L., Rebibou, J.-M., Legendre, M. Clin J Am Soc Nephrol
  Background and objectives The prognosis of patients undergoing kidney tumor resection or kidney donation is linked to many histologic criteria. These criteria notably include glomerular density, glomerular volume, vascular luminal stenosis, and severity of interstitial fibrosis/tubular (...)
• 19:00
  Use and Outcomes of Induction Therapy in Well-Matched Kidney Transplant Recipients - Evans, R. D. R., Lan, J. H., Kadatz, M., Brar, S., Chang, D. T., McMichael, L., Gill, J., Gill, J. S. Clin J Am Soc Nephrol
  Background and objectives The optimal induction treatment in low–immune risk kidney transplant recipients is uncertain. We therefore investigated the use and outcomes of induction immunosuppression in a low-risk cohort of patients who were well matched with their donor at HLA-A, -B, -DR, -DQB1 (...)
• 19:00
  Kidney Disease Prevalence in Transgender Individuals - Eckenrode, H. E., Gutierrez, O. M., Osis, G., Agarwal, A., Curtis, L. M. Clin J Am Soc Nephrol
• 19:00
  Effects of the 2021 CKD-EPI Creatinine eGFR Equation among a National US Veteran Cohort - Gregg, L. P., Richardson, P. A., Akeroyd, J., Matheny, M. E., Virani, S. S., Navaneethan, S. D. Clin J Am Soc Nephrol
• 19:00
  Long-Term Infectious Complications of Kidney Transplantation - Agrawal, A., Ison, M. G., Danziger-Isakov, L. Clin J Am Soc Nephrol
  Infections remain a common complication of solid-organ transplantation. Most infections in the first month after transplant are typically health care–associated infections, whereas late infections, beyond 6–12 months, are community-acquired infections. Opportunistic infections most frequently (...)
• 19:00
  Long-Term Care of the Pediatric Kidney Transplant Recipient - Fernandez, H. E., Foster, B. J. Clin J Am Soc Nephrol
  Pediatric kidney transplant recipients are distinguished from adult recipients by the need for many decades of graft function, the potential effect of CKD on neurodevelopment, and the changing immune environment of a developing human. The entire life of an individual who receives a transplant (...)
• 19:00
  The Use of Serological Tests in the Care of Patients with Lupus Nephritis - Ayoub, I., Rovin, B. H. Clin J Am Soc Nephrol
• 19:00
  Blood Pressure Management in the Patient with Chronic Kidney Disease - Muntner, P., Cushman, W. C., Lerma, E. V. Clin J Am Soc Nephrol
• 19:00
  Introducing Nephrocardiology - Hatamizadeh, P. Clin J Am Soc Nephrol
• 19:00
  Use of Race in Kidney Research and Medicine: Concepts, Principles, and Practice - Mohottige, D., Boulware, L. E., Ford, C. L., Jones, C., Norris, K. C. Clin J Am Soc Nephrol
  Black Americans and other racially and ethnically minoritized individuals are disproportionately burdened by higher morbidity and mortality from kidney disease when compared with their White peers. Yet, kidney researchers and clinicians have struggled to fully explain or rectify causes of these (...)
• 19:00
  The Myeloid-Kidney Interface in Health and Disease - Vlasschaert, C., Moran, S. M., Rauh, M. J. Clin J Am Soc Nephrol
  Kidney homeostasis is highly dependent upon the correct functioning of myeloid cells. These cells form a distributed surveillance network throughout the kidney, where they play an integral role in the response to organ threat. Dysregulation of resident proinflammatory and profibrotic (...)

7 January

Clin J Am Soc Nephrol https://cjasn.asnjournals.org/

• 19:00
  An Honorable and Ongoing Fight: Protecting Organ Transplant Recipients against COVID-19 in the Age of Disinformation - Conway, P. T. Clin J Am Soc Nephrol
• 19:00
  Protection against SARS-CoV-2 Variants with COVID-19 Vaccination in Kidney Transplant Recipients - Bertrand, D., Candon, S. Clin J Am Soc Nephrol
• 19:00
  Waitlist Mortality for Second Kidney Transplants - Fallahzadeh, M. K., Birdwell, K. A. Clin J Am Soc Nephrol
• 19:00
  Accessibility of Nutrition Care for Kidney Disease Worldwide - Iyengar, A., Luyckx, V. A. Clin J Am Soc Nephrol
• 19:00
  Trial Outcomes in Glomerular Diseases - Troost, J. P. Clin J Am Soc Nephrol
• 19:00
  Value-Based Care in Chronic Kidney Disease: Missing Albuminuria is a Missed Opportunity - Reaves, A. C., Weiner, D. E. Clin J Am Soc Nephrol
• 19:00
  Kidney Failure Risk Equation and Cost of Care in Patients with Chronic Kidney Disease - Prasad, B., Osman, M., Jafari, M., Gordon, L., Tangri, N., Ferguson, T. W., Jin, S., Kappel, J., Kozakewycz, D. Clin J Am Soc Nephrol
  Background and objectives Patients with CKD exhibit heterogeneity in their rates of progression to kidney failure. The kidney failure risk equation (KFRE) has been shown to accurately estimate progression to kidney failure in adults with CKD. Our objective was to determine health care (...)
• 19:00
  Circulating Plasma Biomarkers in Biopsy-Confirmed Kidney Disease - Schmidt, I. M., Sarvode Mothi, S., Wilson, P. C., Palsson, R., Srivastava, A., Onul, I. F., Kibbelaar, Z. A., Zhuo, M., Amodu, A., Stillman, I. E., Rennke, H. G., Humphreys, B. D., Waikar, S. S. Clin J Am Soc Nephrol
  Background and objectives Biomarkers for noninvasive assessment of histopathology and prognosis are needed in patients with kidney disease. Design, setting, participants, & measurements Using a proteomics assay, we measured a multimarker panel of 225 circulating plasma proteins in a (...)
• 19:00
  Assessing Global Kidney Nutrition Care - Wang, A. Y.-M., Okpechi, I. G., Ye, F., Kovesdy, C. P., Brunori, G., Burrowes, J. D., Campbell, K., Damster, S., Fouque, D., Friedman, A. N., Garibotto, G., Guebre-Egziabher, F., Harris, D., Iseki, K., Jha, V., Jindal, K., Kalantar-Zadeh, K., Kistler, B., Kopple, J. D., Kuhlmann, M., Lunney, M., Mafra, D., Malik, C., Moore, L. W., Price, S. R., Steiber, A., Wanner, C., ter Wee, P., Levin, A., Johnson, D. W., Bello, A. K. Clin J Am Soc Nephrol
  Background and objectives Nutrition intervention is an essential component of kidney disease management. This study aimed to understand current global availability and capacity of kidney nutrition care services, interdisciplinary communication, and availability of oral nutrition supplements. (...)
• 19:00
  A Core Outcome Set for Trials in Glomerular Disease: A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder Workshops - Carter, S. A., Lightstone, L., Cattran, D., Tong, A., Bagga, A., Barbour, S. J., Barratt, J., Boletis, J., Caster, D. J., Coppo, R., Fervenza, F. C., Floege, J., Hladunewich, M. A., Hogan, J. J., Kitching, A. R., Lafayette, R. A., Malvar, A., Radhakrishnan, J., Rovin, B. H., Scholes-Robertson, N., Trimarchi, H., Zhang, H., Anumudu, S., Cho, Y., Gutman, T., OLone, E., Viecelli, A. K., Au, E., Azukaitis, K., Baumgart, A., Bernier-Jean, A., Dunn, L., Howell, M., Ju, A., Logeman, C., Nataatmadja, M., Sautenet, B., Sharma, A., Craig, J. C., on behalf of the SONG-GD Workshop (...) Clin J Am Soc Nephrol
  Background and objectives Outcomes reported in trials in adults with glomerular disease are often selected with minimal patient input, are heterogeneous, and may not be relevant for clinical decision making. The Standardized Outcomes in Nephrology–Glomerular Disease (SONG-GD) initiative aimed (...)
• 19:00
  Using a Multi-Institutional Pediatric Learning Health System to Identify Systemic Lupus Erythematosus and Lupus Nephritis: Development and Validation of Computable Phenotypes - Wenderfer, S. E., Chang, J. C., Goodwin Davies, A., Luna, I. Y., Scobell, R., Sears, C., Magella, B., Mitsnefes, M., Stotter, B. R., Dharnidharka, V. R., Nowicki, K. D., Dixon, B. P., Kelton, M., Flynn, J. T., Gluck, C., Kallash, M., Smoyer, W. E., Knight, A., Sule, S., Razzaghi, H., Bailey, L. C., Furth, S. L., Forrest, C. B., Denburg, M. R., Atkinson, M. A. Clin J Am Soc Nephrol
  Background and objectives Performing adequately powered clinical trials in pediatric diseases, such as SLE, is challenging. Improved recruitment strategies are needed for identifying patients. Design, setting, participants, & measurements Electronic health record algorithms were developed (...)
• 19:00
  Nocturnal Dipping and Left Ventricular Mass Index in the Chronic Kidney Disease in Children Cohort - Bakhoum, C. Y., Katz, R., Samuels, J. A., Al-Rousan, T., Furth, S. L., Ix, J. H., Garimella, P. S. Clin J Am Soc Nephrol
  Background and objectives The physiologic nocturnal BP decline is often blunted in patients with CKD; however, the consequences of BP nondipping in children are largely unknown. Our objective was to determine risk factors for nondipping and to investigate if nondipping is associated with (...)
• 19:00
  Temporal Trends of Dietary Risk Factors after a Diagnosis of Kidney Stones - Ferraro, P. M., Cunha, T. D. S., Taylor, E. N., Curhan, G. C. Clin J Am Soc Nephrol
  Background and objectives Diet is an important contributor to kidney stone formation, but there are limited data regarding long-term changes in dietary factors after a kidney stone. Design, setting, participants & measurements We analyzed data from three longitudinal cohorts, the Health (...)
• 19:00
  Waiting Time for Second Kidney Transplantation and Mortality - Kainz, A., Kammer, M., Reindl-Schwaighofer, R., Strohmaier, S., Petr, V., Viklicky, O., Abramowicz, D., Naik, M., Mayer, G., Oberbauer, R. Clin J Am Soc Nephrol
  Background and objectives The median kidney transplant half-life is 10–15 years. Because of the scarcity of donor organs and immunologic sensitization of candidates for retransplantation, there is a need for quantitative information on if and when a second transplantation is no longer (...)
• 19:00
  Neutralization of SARS-CoV-2 Variants of Concern in Kidney Transplant Recipients after Standard COVID-19 Vaccination - Benning, L., Morath, C., Bartenschlager, M., Nusshag, C., Ka?lble, F., Buylaert, M., Schaier, M., Beimler, J., Klein, K., Grenz, J., Reichel, P., Hidmark, A., Ponath, G., To?llner, M., Reineke, M., Rieger, S., To?nshoff, B., Schnitzler, P., Zeier, M., Su?sal, C., Bartenschlager, R., Speer, C. Clin J Am Soc Nephrol
  Background and objectives Antibody response after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination is impaired in kidney transplant recipients. Emerging variants, such as B.1.617.2 (), are of particular concern because of their higher transmissibility and partial immune (...)
• 19:00
  Monitoring Daily Ultrafiltration in Automated Peritoneal Dialysis - Eibensteiner, F., Flores, K. O., Unterwurzacher, M., Herzog, R., Kratochwill, K., Alper, S. L., Aufricht, C., Ko?nig, F., Vychytil, A. Clin J Am Soc Nephrol
• 19:00
  Cerebrovascular Response during Acute Exercise in Kidney Transplant Recipients - Ward, J. L., Ramakrishnan, M., Jurgensen, A., Billinger, S., Gupta, A. Clin J Am Soc Nephrol
• 19:00
  Post-Transplant Pregnancy and Contraception - Klein, C. L., Josephson, M. A. Clin J Am Soc Nephrol
  Placed in a historical context, this overview focuses on post-transpant pregnancy, fatherhood, and contraception in women and men. The critical importance of early reproductive counseling because of improved sexual function and the early return of ovulation and menses post-transplant is (...)
• 19:00
  Bone and Mineral Disease in Kidney Transplant Recipients - Khairallah, P., Nickolas, T. L. Clin J Am Soc Nephrol
  After kidney transplantation, mineral and bone disorders are associated with higher risk of fractures and consequent morbidity and mortality. Disorders of calcium and phosphorus, vitamin D deficiency, and hyperparathyroidism are also common. The epidemiology of bone disease has evolved over the (...)
• 19:00
  Optimizing Renin-Angiotensin System Inhibitor Use in CKD - Chang, T. I., Lerma, E. V. Clin J Am Soc Nephrol
• 19:00
  Assessing Risk of Progression in ADPKD - Gordon, C. E., Miskulin, D. C., Perrone, R. D. Clin J Am Soc Nephrol
• 19:00
  The Kidney in Normal Aging: A Comparison with Chronic Kidney Disease - Denic, A., Glassock, R. J., Rule, A. D. Clin J Am Soc Nephrol
• 19:00
  Terlipressin: Hopes Fulfilled or Dashed? - Pichler, R. H., Swenson, E. R., Leary, P. J., Paine, C. H. Clin J Am Soc Nephrol
• 19:00
  Guidelines for Genetic Testing and Management of Alport Syndrome - Savige, J., Lipska-Zietkiewicz, B. S., Watson, E., Hertz, J. M., Deltas, C., Mari, F., Hilbert, P., Plevova, P., Byers, P., Cerkauskaite, A., Gregory, M., Cerkauskiene, R., Ljubanovic, D. G., Becherucci, F., Errichiello, C., Massella, L., Aiello, V., Lennon, R., Hopkinson, L., Koziell, A., Lungu, A., Rothe, H. M., Hoefele, J., Zacchia, M., Martic, T. N., Gupta, A., van Eerde, A., Gear, S., Landini, S., Palazzo, V., al-Rabadi, L., Claes, K., Corveleyn, A., Van Hoof, E., van Geel, M., Williams, M., Ashton, E., Belge, H., Ars, E., Bierzynska, A., Gangemi, C., Renieri, A., Storey, H., (...) Clin J Am Soc Nephrol
  Genetic testing for pathogenic COL4A3–5 variants is usually undertaken to investigate the cause of persistent hematuria, especially with a family history of hematuria or kidney function impairment. Alport syndrome experts now advocate genetic testing for persistent hematuria, even when a (...)
• 19:00
  Platelet Abnormalities in CKD and Their Implications for Antiplatelet Therapy - Baaten, C. C. F. M. J., Schro?er, J. R., Floege, J., Marx, N., Jankowski, J., Berger, M., Noels, H. Clin J Am Soc Nephrol
  Patients with CKD display a significantly higher risk of cardiovascular and thromboembolic complications, with around half of patients with advanced CKD ultimately dying of cardiovascular disease. Paradoxically, these patients also have a higher risk of hemorrhages, greatly complicating patient (...)

7 December

Clin J Am Soc Nephrol https://cjasn.asnjournals.org/

• 20:35
  Patient Views on Telehealth for Kidney Disease Care - Glennon, J. Clin J Am Soc Nephrol
• 20:35
  Atrasentan: The Difficult Task of Integrating Endothelin A Receptor Antagonists into Current Treatment Paradigm for Diabetic Kidney Disease - Ortiz, A., Fernandez-Fernandez, B. Clin J Am Soc Nephrol
• 20:35
  APOL1 Kidney Risk Variants and Acute Kidney Injury in Those with COVID-19: True Association or Red Herring? - Gadegbeku, C. A., Sedor, J. R. Clin J Am Soc Nephrol
• 20:35
  Should We Let Dialysis Patients Eat Their Fruits and Veggies? - Kovesdy, C. P. Clin J Am Soc Nephrol
• 20:35
  Telehealth and Kidney Disease Care: Role after the Public Health Emergency? - Lew, S. Q., Sikka, N. Clin J Am Soc Nephrol
• 20:35
  Time to Abandon Kidney Biopsy to Diagnose Membranous Nephropathy? - Ronco, P., Plaisier, E. Clin J Am Soc Nephrol
• 20:35
  APOL1 Risk Variants and Acute Kidney Injury in Black Americans with COVID-19 - Larsen, C. P., Wickman, T. J., Braga, J. R., Matute-Trochez, L. A., Hasty, A. E., Buckner, L. R., Arthur, J. M., Haun, R. S., Velez, J. C. Q. Clin J Am Soc Nephrol
  Background and objectives Black Americans have a higher incidence of kidney disease compared with populations that do not have recent African ancestry. Two risk variants in the APOL1 are responsible for a portion of this higher risk. We sought to assess the odds of AKI conferred by APOL1 risk (...)
• 20:35
  Association of Polypharmacy with Kidney Disease Progression in Adults with CKD - Kimura, H., Tanaka, K., Saito, H., Iwasaki, T., Oda, A., Watanabe, S., Kanno, M., Shimabukuro, M., Asahi, K., Watanabe, T., Kazama, J. J. Clin J Am Soc Nephrol
  Background and objective Polypharmacy is common in patients with CKD and reportedly associated with adverse outcomes. However, its effect on kidney outcomes among patients with CKD has not been adequately elucidated. Hence, this investigation was aimed at exploring the association between (...)
• 20:35
  Change in Physical Activity and Function in Patients with Baseline Advanced Nondialysis CKD - Rampersad, C., Darcel, J., Harasemiw, O., Brar, R. S., Komenda, P., Rigatto, C., Prasad, B., Bohm, C., Tangri, N. Clin J Am Soc Nephrol
  Background and objectives Although progressive decline in physical activity and function are common in individuals with worsening CKD, little is known about the effect of dialysis initiation on physical activity. We assessed for any association of progression to dialysis in people with (...)
• 20:35
  Video-Based Telemedicine for Kidney Disease Care: A Scoping Review - Young, A., Orchanian-Cheff, A., Chan, C. T., Wald, R., Ong, S. W. Clin J Am Soc Nephrol
  Background and objectives Video-based telemedicine provides an alternative health care delivery model for patients with CKD. The objective was to provide an overview of the available evidence on the implementation and outcomes of adopting video-based telemedicine in nephrology. Design, (...)
• 20:35
  The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function: A Post Hoc Analysis of the SONAR Randomized Trial - Waijer, S. W., Gansevoort, R. T., Bakris, G. L., Correa-Rotter, R., Hou, F.-F., Kohan, D. E., Kitzman, D. W., Makino, H., McMurray, J. J. V., Perkovic, V., Tobe, S., Parving, H.-H., de Zeeuw, D., Heerspink, H. J. L. Clin J Am Soc Nephrol
  Background and objectives Atrasentan reduces the risk of kidney failure but increases the risk of edema and, possibly, heart failure. Patients with severe CKD may obtain greater absolute kidney benefits from atrasentan but may also be at higher risk of heart failure. We assessed relative and (...)
• 20:35
  Noninvasive Diagnosis of PLA2R-Associated Membranous Nephropathy: A Validation Study - Bobart, S. A., Han, H., Tehranian, S., De Vriese, A. S., Roman, J. C. L., Sethi, S., Zand, L., Andrades Gomez, C., Giesen, C. D., Soler, M. J., Bomback, A. S., Fervenza, F. C. Clin J Am Soc Nephrol
  Background and objectives Kidney biopsy is the current gold standard to diagnose membranous nephropathy. Approximately 70%–80% of patients with primary membranous nephropathy have circulating anti-phospholipase A2 receptor antibodies. We previously demonstrated that in proteinuric patients with (...)
• 20:35
  Collectin11 and Complement Activation in IgA Nephropathy - Wei, M., Guo, W.-y., Xu, B.-y., Shi, S.-f., Liu, L.-j., Zhou, X.-j., Lv, J.-c., Zhu, L., Zhang, H. Clin J Am Soc Nephrol
  Background and objectives IgA nephropathy is the most common primary GN worldwide. Previous research demonstrated that collectin11, an initiator of the complement lectin pathway, was involved in both AKI and chronic tubulointerstitial fibrosis. Here, we investigated the potential role of (...)
• 20:35
  Dietary Potassium Intake and All-Cause Mortality in Adults Treated with Hemodialysis - Bernier-Jean, A., Wong, G., Saglimbene, V., Ruospo, M., Palmer, S. C., Natale, P., Garcia-Larsen, V., Johnson, D. W., Tonelli, M., Hegbrant, J., Craig, J. C., Teixeira-Pinto, A., Strippoli, G. F. M. Clin J Am Soc Nephrol
  Background and objectives Dietary potassium restriction in people receiving maintenance hemodialysis is standard practice and is recommended in guidelines, despite a lack of evidence. We aimed to assess the association between dietary potassium intake and mortality and whether hyperkalemia (...)
• 20:35
  Racial Disparities in Pediatric Kidney Transplantation under the New Kidney Allocation System in the United States - Krissberg, J. R., Kaufmann, M. B., Gupta, A., Bendavid, E., Stedman, M., Cheng, X. S., Tan, J. C., Grimm, P. C., Chaudhuri, A. Clin J Am Soc Nephrol
  Background and objectives In December 2014, the Kidney Allocation System (KAS) was implemented to improve equity in access to transplantation, but preliminary studies in children show mixed results. Thus, we aimed to assess how the 2014 KAS policy change affected racial and ethnic disparities (...)
• 20:35
  Humoral Response to BNT162b2 mRNA SARS-CoV-2 Vaccine in Patients with Nondialysis Chronic Kidney Disease - Kervella, D., Braud, P., Garandeau, C., Phelizot, C., Ambrosi, X., Blancho, G., Hourmant, M., Figueres, L., the Divat Consortium, Blancho, Branchereau, Cantarovich, Chapelet, Dantal, Deltombe, Figueres, Gaisne, Garandeau, Giral, Gourraud-Vercel, Hourmant, Karam, Kerleau, Kervella, Masset, Meurette, Ville, Kandell, Moreau, Renaudin, Delbos, Walencik, Devis Clin J Am Soc Nephrol
• 20:35
  Humoral Response to One and Two Doses of ChAdOx1-S Vaccine in Patients on Hemodialysis - Yadav, A. K., Gondil, V. S., Singla, M., Goyal, A., Kaushal, R., Chauhan, M., Jha, V. Clin J Am Soc Nephrol
• 20:35
  Correction: Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood Clin J Am Soc Nephrol
• 20:35
  Post-Transplant Cardiovascular Disease - Birdwell, K. A., Park, M. Clin J Am Soc Nephrol
  Cardiovascular disease remains a leading cause of death and morbidity in kidney transplant recipients and a common reason for post-transplant hospitalization. Several traditional and nontraditional cardiovascular risk factors exist, and many of them present pretransplant and worsened, in part, (...)
• 20:35
  Thinking Outside the Box: Novel Kidney Protective Strategies in Kidney Transplantation - Ibrahim, H. N., Murad, D. N., Knoll, G. A. Clin J Am Soc Nephrol
  Despite the reduction in the incidence of acute rejection, a major risk factor for graft loss, there has been only modest improvement in long-term graft survival. Most cases of kidney graft loss have an identifiable cause that is not idiopathic fibrosis/atrophy or calcineurin inhibitor (...)
• 20:35
  Kidney Replacement Therapy for Patients Requiring Cardiopulmonary Bypass Support during Cardiac Surgery - Stevens, J. S., Radhakrishnan, J. Clin J Am Soc Nephrol
• 20:35
  A Body Size-Adjusted Maximum Ultrafiltration Rate Warning Level Is Not Equitable for Larger Patients - Daugirdas, J. T. Clin J Am Soc Nephrol
• 20:35
  Food Insecurity and Kidney Disease: Symptoms of Structural Racism - Mokiao, R., Hingorani, S. Clin J Am Soc Nephrol
• 20:35
  What Is the Best Maintenance Therapy for ANCA Vasculitis? - Woerner, K., Nachman, P. H. Clin J Am Soc Nephrol
• 20:35
  When and How Is It Possible to Stop Therapy in Patients with Lupus Nephritis: A Narrative Review - Moroni, G., Frontini, G., Ponticelli, C. Clin J Am Soc Nephrol
  Glucocorticoids and other immunosuppressants still represent the cornerstone drugs for the management of SLE and lupus nephritis. The refined use of these drugs over the years has allowed us to obtain stable disease remission and improvement of long-term kidney and patient survival. (...)
• 20:35
  Classification of Uremic Toxins and Their Role in Kidney Failure - Rosner, M. H., Reis, T., Husain-Syed, F., Vanholder, R., Hutchison, C., Stenvinkel, P., Blankestijn, P. J., Cozzolino, M., Juillard, L., Kashani, K., Kaushik, M., Kawanishi, H., Massy, Z., Sirich, T. L., Zuo, L., Ronco, C. Clin J Am Soc Nephrol
  Advances in our understanding of uremic retention solutes, and improvements in hemodialysis membranes and other techniques designed to remove uremic retention solutes, offer opportunities to readdress the definition and classification of uremic toxins. A consensus conference was held to develop (...)

8 November

Clin J Am Soc Nephrol https://cjasn.asnjournals.org/

• 20:40
  Understanding Fatigue with Kidney Disease: A Kidney Patients Journey with Post-Transplant Fatigue - Forfang, D. Clin J Am Soc Nephrol
• 20:40
  Muscle Abnormalities with Kidney Failure - Barany, P. Clin J Am Soc Nephrol
• 20:40
  Coffee Metabolites and Kidney Disease: Answers or More Questions? - Cornelis, M. C., Burton-Freeman, B. Clin J Am Soc Nephrol
• 20:40
  ANCA Vasculitis Treatment in the Dialysis Patient: Caution Needed! - Hendren, E., Radhakrishnan, J. Clin J Am Soc Nephrol
• 20:40
  Metabolites Associated with Coffee Consumption and Incident Chronic Kidney Disease - He, W. J., Chen, J., Razavi, A. C., Hu, E. A., Grams, M. E., Yu, B., Parikh, C. R., Boerwinkle, E., Bazzano, L., Qi, L., Kelly, T. N., Coresh, J., Rebholz, C. M. Clin J Am Soc Nephrol
  Background and objectives Moderate coffee consumption has been associated with lower risk of CKD; however, the exact biologic mechanisms underlying this association are unknown. Metabolomic profiling may identify metabolic pathways that explain the association between coffee and CKD. The goal (...)
• 20:40
  Family Members Understanding of the End-of-Life Wishes of People Undergoing Maintenance Dialysis - Saeed, F., Butler, C. R., Clark, C., OLoughlin, K., Engelberg, R. A., Hebert, P. L., Lavallee, D. C., Vig, E. K., Tamura, M. K., Curtis, J. R., OHare, A. M. Clin J Am Soc Nephrol
  Background and objectives People receiving maintenance dialysis must often rely on family members and other close persons to make critical treatment decisions toward the end of life. Contemporary data on family members’ understanding of the end-of-life wishes of members of this population are (...)
• 20:40
  C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and Outcomes - Wong, E. K. S., Marchbank, K. J., Lomax-Browne, H., Pappworth, I. Y., Denton, H., Cooke, K., Ward, S., McLoughlin, A.-C., Richardson, G., Wilson, V., Harris, C. L., Morgan, B. P., Hakobyan, S., McAlinden, P., Gale, D. P., Maxwell, H., Christian, M., Malcomson, R., Goodship, T. H. J., Marks, S. D., Pickering, M. C., Kavanagh, D., Cook, H. T., Johnson, S. A., on behalf of the MPGN/DDD/C3 Glomerulopathy Rare Disease Group and National Study of MPGN/DDD/C3 Glomerulopathy Investigators, Brimble, Cook, Gale, Gibbs, Gilbert, Harper, Harris, Jessup, Johnson, Jones, Kavanagh, Levine, Lomax-Browne, (...) Clin J Am Soc Nephrol
  Background and objectives Membranoproliferative GN and C3 glomerulopathy are rare and overlapping disorders associated with dysregulation of the alternative complement pathway. Specific etiologic data for pediatric membranoproliferative GN/C3 glomerulopathy are lacking, and outcome data are (...)
• 20:40
  Poly-IgA Complexes and Disease Severity in IgA Nephropathy - Zhang, X., Lv, J., Liu, P., Xie, X., Wang, M., Liu, D., Zhang, H., Jin, J. Clin J Am Soc Nephrol
  Background and objectives Poly-IgA immune complex formation and glomerular deposition play a key role in IgA nephropathy. Our study sought to develop a new methodology for one-step serologic detection of poly-IgA levels. Design, setting, participants, & measurements A novel ELISA method (...)
• 20:40
  Disease Activity and Adverse Events in Patients with ANCA-Associated Vasculitides Undergoing Long-Term Dialysis - Kauffmann, M., Bobot, M., Robert, T., Burtey, S., Couvrat-Desvergnes, G., Lavainne, F., Puechal, X., Terrier, B., Quemeneur, T., Faguer, S., Karras, A., Brunet, P., Couchoud, C., Jourde-Chiche, N., on behalf of the REIN registry and the French Vasculitis Study Group Clin J Am Soc Nephrol
  Background and objectives Kidney impairment of ANCA-associated vasculitides can lead to kidney failure. Patients with kidney failure may suffer from vasculitis relapses but are also at high risk of infections and cardiovascular events, which questions the maintenance of immunosuppressive (...)
• 20:40
  Skeletal Muscle Phenotype in Patients Undergoing Long-Term Hemodialysis Awaiting Kidney Transplantation - Souweine, J.-S., Gouzi, F., Badia, E., Pomies, P., Garrigue, V., Morena, M., Hayot, M., Mercier, J., Ayoub, B., Quintrec, M. L., Raynaud, F., Cristol, J.-P. Clin J Am Soc Nephrol
  Background and objectives Age and comorbidity-related sarcopenia represent a main cause of muscle dysfunction in patients on long-term hemodialysis. However, recent findings suggest muscle abnormalities that are not associated with sarcopenia. The aim of this study was to isolate functional (...)
• 20:40
  Airflow Limitation, Fatigue, and Health-Related Quality of Life in Kidney Transplant Recipients - Knobbe, T. J., Kremer, D., Eisenga, M. F., van Londen, M., Gomes-Neto, A. W., Douwes, R. M., Gan, C. T., Corpeleijn, E., Annema, C., Navis, G., Berger, S. P., Bakker, S. J. L., on behalf of TransplantLines Investigators, Jong, Bakker, Berger, Blokzijl, Bodewes, de Boer, Damman, de Borst, Diepstra, Dijkstra, Douwes, Eisenga, Erasmus, Gan, Neto, Grootjans, Hak, Heiner-Fokkema, Hepkema, Klont, Knobbe, Kremer, Leuvenink, Lexmond, de Meijer, Niesters, van Pelt, Pol, Porte, Ranchor, Sanders, Schutten, Siebelink, Slart, Swarte, Timens, Touw, van den Heuvel, van Leer-Buter, van Londen, (...) Clin J Am Soc Nephrol
  Background and objectives Many kidney transplant recipients suffer from fatigue and poor health-related quality of life. Airflow limitation may be an underappreciated comorbidity among kidney transplant recipients, which could contribute to fatigue and lower health-related quality of life in (...)
• 20:40
  COVID-19-Associated Mortality among Kidney Transplant Recipients and Candidates in the United States - Mohan, S., King, K. L., Husain, S. A., Schold, J. D. Clin J Am Soc Nephrol
  Background and objectives The coronavirus disease 2019 (COVID-19) pandemic has had a profound effect on transplantation activity in the United States and globally. Several single-center reports suggest higher morbidity and mortality among candidates waitlisted for a kidney transplant and (...)
• 20:40
  Timing of Kidney Clamping and Deceased Donor Kidney Transplant Outcomes - Ville, S., Lorent, M., Kerleau, C., Asberg, A., Legendre, C., Morelon, E., Buron, F., Garrigue, V., Le Quintrec, M., Girerd, S., Ladriere, M., Albano, L., Sicard, A., Glotz, D., Lefaucheur, C., Branchereau, J., Jacobi, D., Giral, M., for the EKiTE Consortium, Reisaeter, Line, Asberg, Blancho, Branchereau, Cantarovich, Chapelet, Dantal, Deltombe, Figueres, Garandeau, Giral, Gourraud-Vercel, Hourmant, Karam, Kerleau, Meurette, Ville, Kandell, Moreau, Renaudin, Delbos, Walencik, Devis, Masset, Kervella, Amrouche, Anglicheau, Aubert, Bererhi, Legendre, Loupy, Martinez, Sberro-Soussan, Scemla, (...) Clin J Am Soc Nephrol
  Background and objectives The fact that metabolism and immune function are regulated by an endogenous molecular clock that generates circadian rhythms suggests that the magnitude of ischemia reperfusion, and subsequent inflammation on kidney transplantation, could be affected by the time of (...)
• 20:40
  Kidney Effects of Empagliflozin in People with Type 1 Diabetes - Cherney, D. Z. I., Bjornstad, P., Perkins, B. A., Rosenstock, J., Neubacher, D., Marquard, J., Soleymanlou, N. Clin J Am Soc Nephrol
• 20:40
  Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients - Mulhern, J. G., Fadia, A., Patel, R., Ficociello, L. H., Willetts, J., Dahne-Steuber, I. A., Pollan, M. C., Mullon, C., DeLisi, J., Johnson, C., Mysayphonh, C., Kossmann, R. J., Anger, M. S., Hymes, J. L. Clin J Am Soc Nephrol
• 20:40
  Chronic Allograft Injury - Langewisch, E., Mannon, R. B. Clin J Am Soc Nephrol
  With the incremental improvements in long-term kidney transplant survival, there is renewed focus on what causes failure of the transplanted allograft. Over the past decade, our understanding of the injuries that lead to loss of graft function over time has evolved. Chronic allograft injury (...)
• 20:40
  Recurrent Glomerular Disease after Kidney Transplantation: Diagnostic and Management Dilemmas - Uffing, A., Hullekes, F., Riella, L. V., Hogan, J. J. Clin J Am Soc Nephrol
  Recurrent glomerular disease after kidney transplant remains an important cause of allograft failure. Many of the different entities post-transplant still suffer from incomplete knowledge on pathophysiology, and therefore lack targeted and effective therapies. In this review, we focus on (...)
• 20:40
  Could This Be Alport Syndrome? - Lennon, R., Fornoni, A. Clin J Am Soc Nephrol
• 20:40
  COVID-19 Vaccination Imperatives in People on Maintenance Dialysis: An International Perspective - Blake, P. G., Hladunewich, M. A., Oliver, M. J. Clin J Am Soc Nephrol
• 20:40
  Training Nephrology Fellows in Home Dialysis in the United States - Gupta, N., Miller, B. W. Clin J Am Soc Nephrol
• 20:40
  The Future Nephrology Workforce: There Will Be One - Parker, M. G., Sozio, S. M. Clin J Am Soc Nephrol
• 20:40
  Evidence For and Against Direct Kidney Infection by SARS-CoV-2 in Patients with COVID-19 - Hassler, L., Reyes, F., Sparks, M. A., Welling, P., Batlle, D. Clin J Am Soc Nephrol
  Despite evidence of multiorgan tropism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with coronavirus disease 2019 (COVID-19), direct viral kidney invasion has been difficult to demonstrate. The question of whether SARS-CoV2 can directly infect the kidney is (...)
• 20:40
  Kidney Disease among People Who Are Incarcerated - Murphy, M., Ding, A., Berk, J., Rich, J., Bayliss, G. Clin J Am Soc Nephrol
  CKD affects 15% of US adults and is associated with higher morbidity and mortality. CKD disproportionately affects certain populations, including racial and ethnic minorities and individuals from disadvantaged socioeconomic backgrounds. These groups are also disproportionately affected by (...)